---
$id: https://graph.org.ai/products/commodity/51372104
$type: Product
source: UNSPSC
code: "51372104"
title: "Dihydrocodeine"
class: "51372100"
classTitle: "Controlled substance analgesic morphine derivatives"
family: "51370000"
familyTitle: "Controlled substance analgesics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Dihydrocodeine

**UNSPSC Code**: 51372104
**Class**: [Controlled substance analgesic morphine derivatives](Controlled substance analgesic morphine derivatives.mdx)
**Family**: [Controlled substance analgesics](../Controlled substance analgesics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an opioid receptor agonist and opioid with the molecular formula C18H23NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier N9I9HDB855, chemically known as 7, 8-dihydrocodeine but generally known as dihydrocodeine, which bears US NIH Compound Identifier 3063. European Medicines Agency schedules Dihydrocodeine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07138MIG. The term DIHYDROCODEINE is an International Non-Proprietary Name. World Health Organization schedules dihydrocodeine in its Anatomical Therapeutic Chemical (ATC) Classification. DIHYDROCODEINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule dihydrocodeine under HS 29391100 and SITC 54141. As of Q4 2014, DIHYDROCODEINE remains the US FDA Preferred Term for this commodity. Dihydrocodeine bears US NLM identifiers UMLS ID C0058056 and NCI Concept Code C84508. SMILES: O1C2C34C(C(N(CC3)C)CC3C4C1C(OC)CC3)CCC2O.

